(Adds economist quote and details throughout; updates prices)
* Canadian dollar gains 0.5% against the greenback
* Bank of Canada holds benchmark interest rate at 0.25%
* Canadian manufacturing sales rise 10.7% in May
* Canada-U.S. 10-year spread widens by 1.7 basis points
By Fergal Smith
TORONTO, July 15 (Reuters) - The Canadian dollar rose against the greenback on Wednesday as investors grew more optimistic about a COVID-19 vaccine and after the Bank of Canada reinforced its commitment to support economic recovery.
Canada's economic growth will not return to pre-pandemic levels until 2022, the Bank of Canada said, in an outlook that was cautious on U.S. growth. It left its benchmark interest rate at 0.25%, a level it considers to be the floor, and said it would remain at that level until economic slack is absorbed.
"The BoC remains all-in in terms of its commitment to stimulus in order to support the recovery of the economy," said Ryan Brecht, a senior economist at Action Economics.
World shares climbed toward a four-month high after
U.S. researchers reported that Moderna Inc's
Canada runs a current account deficit and is a major exporter of commodities, including oil, so the loonie tends to be sensitive to the global flow of trade and capital.
U.S. crude
The Canadian dollar
Canadian factory sales jumped by a record 10.7% in May from April as many manufacturers resumed operations following partial shutdowns related to the coronavirus outbreak, Statistics Canada said. Analysts in a Reuters poll had forecast a gain of 9.5% in May.
Canada's 10-year
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.